This isn’t about managing the AIDS pandemic. It’s about ending it — and letting a new generation grow and thrive free of its threat.
Lenacapavir, developed by Gilead Sciences, is a twice-yearly injectable for HIV prevention.
The First Generation Without AIDS Is Within Reach If We Refuse To Settle
